Mesoblast Limited Information
Contact top employees from
Mesoblast Limited
Summary
Mesoblast Limited is a public company that has been in the industry for 22 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the Managing Director & CEO is occupied by Silviu Itescu. Its headquarters is located at Melbourne, Victoria, AU. The number of employees ranges from 100 to 250. The annual revenue of Mesoblast Limited varies between 5.0M and 25M. Total funding of the company - $567.4M. To connect with Mesoblast Limited employee register on SignalHire.
Organization Website | mesoblast.com |
Social Links |   |
Phone Number | +61419228128 |
Industries | |
Headquarters Location | Level 38, 55 Collins St, Melbourne, VIC, 3000 AU |
Employees Size | 100-200 employees |
Specialties | Cell-based therapies, cellular medicines, Mesenchymal Lineage Adult Stem Cells, regenerative medicine, COVID-19, Chronic Heart Failure, Graft Versus Host Disease, Chronic Low Back Pain, Rheumatoid Arthritis |
SIC Code | 2836 |
Founded | 2004 |
Estimated Annual Revenue | $5.0M - 25M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1995 | Public Company | 25 - 100 | 1.3M | $145.8M | |
| 2012 | Public Company | 100 - 250 | 24M | $23.3M | |
| 2006 | Public Company | 1 - 25 | 16M | $153.7M | |
| 2016 | Privately Held | 25 - 100 | < 1M | $133M |
Employees Turnover 4 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Mesoblast Limited shows a diverse range of experience levels:
8% have been with the company for less than 1 year11% for 1–2 years6% for 3–4 years17% for 5–7 years11% for 8–10 years47% have over 11 years of service at Mesoblast LimitedEx-employees positions
In Company
In New Company
Contact top employees from
Mesoblast Limited
Thomas Ross
Senior Vice President, Head of Legal
Christopher James
Vice President, Clinical Operations
Geraldine Storton
Head of Regulatory Affairs and Quality Management
Roger Brown
Therapeutic Business Unit Head, Musculoskeletal Repair
Marcelo Santoro
Chief Commercial Officer
Jeremy Clarke
Product Champion
Andy Schlechter
Key Account Manager
Benjamin Smith
Senior Process Engineer
Dagmar Rosa
Strategy consulting
Sushrut Arora
Laboratory Manager
Billy Chung
Regulatory Publishing Associate
Paul Nunnally
Key Account Manager
Catherine deSombre
Director of Analytical Services
Samantha Romig
Clinical Supply Manager
Ulrike Rawiel
Associate Director, Data Management
Erin Lowry
QA Operations Sr Manager
Meena Taneja
Pharmacovigilance Manager at Mesoblast Inc.
David Yang
Sr. Clinical Scientist
Darryl Forest
Transplant Key Account Manager
Susan Sukovich
Senior Director Regulatory Affairs
Suman Abraham
Manufacturing Technology, Senior Director
Wendy Shiels
Business Analyst
Vonny Ivon Leo
Process Development Associate
Darren Johnson
Medical Science Liaison
Mandeep Singh
Accountant
Sophia Palmer
Chief Financial Officer
Similar Companies
FAQ
Mesoblast Limited operates in the Biotech industries. More details can be found on the official website: mesoblast.com.
The headquarters of Mesoblast Limited are located in Melbourne, Australia.
The current CEO of Mesoblast Limited is Silviu Itescu
You can contact Mesoblast Limited by phone at +61419228128.
Mesoblast Limited currently employs 100-200 people.
Mesoblast Limited's revenue is approximately 6.2M.
Well-known competitors of Mesoblast Limited include Athersys, Orgenesis Inc., Lisata Therapeutics, Inc. and Surrozen.
